| Date | Title | Description |
| 20.09.2026 | AI Infrastructure Giant Temporal Secures $550M, Valuation Soars to $12.55 Billion | Temporal secured $550 million in Series E funding. This propels its valuation to $12.55 billion. The capital will fuel global expansion and advanced research and development. Temporal's Durable Execution platform delivers critical reliabili... |
| 15.09.2026 | Perk Brings Its Spend Platform to U.S.: NYSE Content Update | NYSE issues a pre-market daily advisory direct from the trading floor.
NEW YORK, Sept. 15, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE ... |
| 14.09.2026 | Temporal Raises $550 Million in Series E Round: NYSE Content Update | NYSE issues a pre-market daily advisory direct from the trading floor.
NEW YORK, Sept. 14, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE ... |
| 10.09.2026 | PW Consulting: Global Sedative-Hypnotic Drug Market Hits $4.85B in 2025, Projected 5.85% CAGR to 2032 | Navigating the Global Sedative-Hypnotic Drug Market: Strategic Imperatives for 2026 and Beyond
The global healthcare landscape is undergoing a significant transformation, driven by an aging population, increasing prevalence of sleep disorde... |
| 09.09.2026 | Беззвучный режим | Беззвучный режим Что мешает борьбе с мигренью
В России каждый пятый человек страдает мигренью — хроническим неврологическим заболеванием, которое проявляется приступами сильной, пульсирующей головной боли. Опросы показывают, что лишь до пол... |
| 01.09.2026 | Sun Pharma signs deal with US government to reduce drug prices | Drug major Sun Pharmaceutical Industries has signed a deal with the US government to lower prices of its innovative drugs in the US, in line with the lowest prices paid by other developed nations, under the most favoured nation (MFN) pricin... |
| 24.07.2026 | Trump's Generic Drug Tariffs: U.S. Onshoring Push Faces Steep Challenges | U.S. faces major generic drug tariff changes. Trump announced duties up to 200% on imported generics. A two-year window encourages domestic manufacturing. This policy aims to onshore critical drug production. Industry concerns are high. Gen... |
| 22.07.2026 | Trump’s generic drug tariffs: What they could mean for medicine prices, manufacturers and supply | Trump plans tariffs of up to 200% on imported generic drugs after a two-year grace period aimed at encouraging U.S. manufacturing.
But thin profit margins make tariffs harder to absorb than for branded medicines and and key policy details r... |
| 09.07.2026 | Immunotherapy Drugs Market to Reach $580.6 Billion by 2029 | The global Immunotherapy drugs market is projected to grow from USD 285.3 billion in 2024 to USD 580.6 billion by 2029, at a robust CAGR of 15.3% during the forecast period. Market growth is driven by advancements in antibody engineering te... |
| 23.06.2026 | Clarivate Releases 2025 Sustainability Report | New report highlights progress against goals and a decline in total carbon emissions
LONDON, June 23, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released its 2025 Sustaina... |
| 24.03.2026 | Fosun Pharma Announces 2025 Annual Results | Innovation and Globalization Propel Fosun Pharma's High-Quality Growth
SHANGHAI, March 24, 2026 /PRNewswire/ -- On 24 March, 2026, Fosun Pharma ("the company", stock code: 600196.SH; 02196.HK), an innovation-driven global pharmace... |
| 05.03.2026 | Defense giant Elbit becomes Israel’s most valuable company, after 45% surge this year | Defense giant Elbit Systems becomes the largest Israeli firm by market value listed on the Tel Aviv Stock Exchange after surpassing Teva Pharmaceuticals Industries and the country’s biggest lenders, Bank Hapoalim and Bank Leumi.
Elbit share... |
| 09.02.2026 | Indiana reaches $6.25M settlement with pharmaceutical companies over EpiPen prices | Please subscribe to IBJ to decode this article.
iiw oofnectst ncoiapcpw> lillau
ser=ctitaeae"s/a-l"tan ahnudcltil igneircnmpnfpes.nisd pEtu nitr ann= apoteletwon-vaeia rroyrGeokhsp"et-snjad aacgir aertowuVist/cuas,"t ... |
| 12.09.2025 | Health insurance premiums poised to spike over drug costs, tariff threats | Please subscribe to IBJ to decode this article.
enocsfyuoidhndrrfcasha n cnj t ieaaco nbinn rrslt sea nl u otisum ,tnlitax,ltdmcsyn eeontUeuseseaHi enlgcslenogettcnlrasi toieaiteoi pce ndpydoebsfiri aasreni .vdtoreal Aueieaelpbenutr a gSa t... |
| 29.08.2025 | Seminar: IP That Matters - Behind Orexo’s Milestone Patent Win at the US Court | Seminar: IP That Matters - Behind Orexo’s Milestone Patent Win at the US Court
Fri, Aug 29, 2025 13:30 CET Report this content
Uppsala, Sweden – August 29, 2025 – Orexo (publ.), (STO:ORX) (OTCQX:ORXOY) in collaboration with its advisory int... |
| 11.07.2025 | "Celebrate!" Great Place To Work™ Greater China Celebrates the Best Workplaces™ in Hong Kong 2025 | HONG KONG, July 11, 2025 /PRNewswire/ -- On July 10th, Great Place To Work™ Greater China held the Best Workplaces™ in Hong Kong 2025 Awards Ceremony at Maggie Choo's.
The Best Workplaces™ in Hong Kong 2025 celebration at Maggie Choo's in H... |
| 16.06.2025 | Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology | Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanoma
Fosun Pharma-Teva collaboration agreement established with goal of accelerating clinical data gener... |
| 14.06.2025 | Israel-Iran attacks and the 2 other things that drove the stock market this week | - |
| 28.05.2025 | Here are Wednesday’s biggest analyst calls: Nvidia, Apple, Broadcom, Microsoft, Teva, AutoZone, Vail and more | - |
| 27.05.2025 | Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma | BD9 is a multibody that targets IL-13 and TSLP, and has potential to treat TH-2-driven inflammatory diseases
BD9 designed using Biolojic’s Multibody Platform, which generates Antibodies capable of addressing multiple disease targets
Collabo... |
| 14.05.2025 | Best stock picks from Sohn hedge fund conference include Wex, Adobe and Teva | - |
| 29.04.2025 | Перечень жизненно важных лекарств не резиновый | - |
| 01.04.2025 | Trump’s tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks | - |
| 15.03.2025 | Drugmakers agree to participate in second round of price negotiations | Drugmakers agree to participate in second round of price negotiations
By ReutersMarch 14, 202511:02 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Item 1 of 2 FILE PHOTO: A view shows the logo ... |
| 14.03.2025 | KLN and Teva: A Strategic Alliance in Pharmaceutical Logistics | In the bustling landscape of the Greater Bay Area, a significant partnership has emerged. Kerry Logistics Network Limited (KLN) has been selected by Teva Pharmaceutical Hong Kong Limited as its exclusive fourth-party logistics (4PL) service... |
| 14.03.2025 | Teva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry Pharma | HONG KONG, March 14, 2025 /PRNewswire/ -- Teva Hong Kong ("Teva"), has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network Ltd ("KLN"). Leveraging Kerry Pharma's extensive logis... |
| 13.03.2025 | KLN Selected by Teva as its Exclusive 4PL Service Provider in the Greater Bay Area | HONG KONG, March 13, 2025 /PRNewswire/ -- Kerry Logistics Network Limited ('KLN'; Stock Code 0636.HK), through its subsidiary, Kerry Pharma, and Teva Pharmaceutical Hong Kong Limited ('Teva') entered into an exclusive agreement for fourth-p... |
| 22.02.2025 | Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease | ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre-specified subgroups across t... |
| 22.02.2025 | Dream: $100 Million (Series B) Raised At $1.1 Billion Valuation For Cyber Resilience | Dream, an AI-based company providing cyber resilience for nations and critical infrastructure, announced a $100 million Series B led by Bain Capital Ventures at a $1.1 billion valuation. And additional investors include Group 11, Tru Arrow,... |
| 22.02.2025 | Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease | ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre-specified subgroups across t... |
| 22.02.2025 | Communiqué de presse : ECCO 2025 : de nouvelles données sur le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de C... | ECCO 2025 : de nouvelles données sur le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn De nouvelles données détaillées de l’étude RELIEVE UCCD at... |
| 21.02.2025 | Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S. | In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of interchangeability for SELARSDI
SELARSD... |
| 27.01.2025 | LinkedIn cofounder launches Manas AI with $24.6M for AI drug discovery | Photo: sanjeri/Getty Images
Manas AI, an AI-driven drug discovery platform, has launched with $24.6 million in seed round in a round coled by General Catalyst and LinkedIn cofounder Reid Hoffman.
Greylock and other strategic investors parti... |
| 20.01.2025 | How Indiana is spending $980M in opioid settlements | - |
| 11.12.2024 | Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients | Teva to provide two generic inhaler products to Direct Relief for its network of free and charitable clinics
The program, launching this month, will run for a minimum of three years
PARSIPPANY, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Teva P... |
| 06.12.2024 | A New Era for GitLab: Bill Staple's Leadership Amidst Change | On December 5, 2024, GitLab announced a significant leadership change. Bill Staple stepped into the role of CEO, replacing Sid Sijbrandij, who has led the company since 2012. This transition is not just a change of guard; it symbolizes a ne... |
| 06.12.2024 | Great Place To Work™ Greater China Celebrates Diversity, Equity, and Inclusion at 2024 Conference and Awards Ceremony | SHANGHAI, Dec. 6, 2024 /PRNewswire/ -- Great Place to Work™ Greater China successfully hosted its 2024 Conference and Awards Ceremony on December 5 at The Peninsula, Shanghai. This prestigious event brought together 200 leaders, HR professi... |
| 22.11.2024 | Converge Bio: The Future of Drug Discovery Speaks the Language of Life | In the world of pharmaceuticals, time is a luxury few can afford. The process of drug discovery is a labyrinthine journey, often taking a decade or more, with costs spiraling past a billion dollars. Yet, a new player has entered the arena, ... |
| 20.11.2024 | Generative AI drug discovery hub Converge Bio raises $5.5M to understand the ‘language of biology’
Your vote of support is important to us and it helps us keep the content FREE.
One click below suppor... | Drug discovery startup Converge Bio Inc. said today it has closed on a $5.5 million seed round of funding to help biotech and pharmaceutical companies develop more effective drugs at faster speeds by leveraging generative artificial intelli... |
| 16.10.2024 | The Rise of Influencer Marketing in Healthcare: A New Era of Patient Engagement | In the world of healthcare, change is the only constant. The latest shift? Influencer marketing. It’s not just a trend; it’s a revolution. Havas Lynx has stepped into the spotlight with a bold new offering that taps into the power of influe... |
| 14.10.2024 | Havas Lynx Launches Global Healthcare Influencer Offering | Havas Lynx announced today the launch of a new global healthcare influencer offering that leverages the power of influencers to drive health outcomes and behaviour change. Havas Lynx’s Dr. Tapas Mukherjee, Medical Director, and Matt Eagles,... |
| 24.09.2024 | Datricks: AI-Based Compliance Platform Company Raises $15 Million (Series A) | Datricks, a pioneering financial integrity platform, announced $15 million in Series A funding led by Team8’s venture capital arm. And SAP, the global leader in enterprise resource planning (ERP) software, made a strategic investment in the... |
| 19.09.2024 | Multi-sponsor Pregnancy Exposure Registries: Physician, Scientific Advisory and Industry Insights, Upcoming Webinar Hosted by Xtalks | www.syneoshealth.com
In this free webinar, learn how pregnancy exposure registries are helping in assessing medication safety and thus enhance pregnancy safety studies. Attendees will learn about the historical context of single- vs multi-s... |
| 12.09.2024 | Qualifyze: Life Sciences Supplier Risk Management Company Raises $54 Million (Series B) | Qualifyze, a supplier risk management company in the Life Sciences industry, announced $54 million in Series B funding from Insight Partners. Existing investors HV Capital, HarbourVest Partners, H14, and Cherry Ventures also participated.
W... |
| 10.09.2024 | Cognition Corporation Launches Compass MED: A Revolutionary Solution to Simplify and Accelerate Medical Device Development | As medical devices become increasingly more complex, the need to enhance development efficiency, quality by design, integrated risk management, and regulatory compliance has never been greater
LEXINGTON, Mass., Sept. 10, 2024 /PRNewswire/ -... |
| 10.09.2024 | Qualifyze Raises $54M in Series B Funding | Qualifyze, a Frankfurt, Germany-based company which specializes in supply chain risk management in the Life Sciences industry, raised $54M in Series B funding.
The round was led by Insight Partners, with participation from existing investor... |
| 03.09.2024 | Pharmaceutical Market: Trends, Segmentation, and Growth Opportunities | Share
Tweet
Share
Share
Email
In recent years, the pharmaceutical market has witnessed remarkable growth and transformation, driven by technological advancements, evolving consumer needs, and the global push for better healthcare solutions.... |
| 03.09.2024 | Parkinson’s Disease Drug Market: Trends, Growth, and Segmentation | Share
Tweet
Share
Share
Email
Parkinson’s disease, a progressive neurodegenerative disorder characterized by motor symptoms such as tremors, rigidity, and bradykinesia, affects millions of individuals worldwide. As the global population age... |
| 03.09.2024 | General Anesthesia Drugs Market: Trends, Segmentation, and Future Outlook | Share
Tweet
Share
Share
Email
The global general anesthesia drugs market has been experiencing significant evolution, driven by advancements in medical technology, increasing surgical procedures, and a growing emphasis on patient safety and... |
| 29.08.2024 | The Future of Pharmaceuticals: Navigating Price Negotiations and Patient Access | The landscape of pharmaceuticals is shifting. The winds of change are blowing through Wall Street and the healthcare system alike. As the U.S. government prepares for drug price negotiations under the Inflation Reduction Act, the stakes are... |
| 28.08.2024 | SAS announces designated Board of Directors | SAS announces designated Board of Directors
Wed, Aug 28, 2024 17:00 CET Report this content
The new principal investors in SAS, Castlelake, Air France-KLM, Lind Invest and the Danish State, have agreed to appoint a new Board of Directors fo... |
| 23.08.2024 | Ozempic on Wall Street's list for 2027 Medicare drug negotiations | Future of HealthOzempic on Wall Street's list for 2027 Medicare drug negotiations
By Michael ErmanAugust 23, 202412:06 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
A box of Ozempic made by No... |
| 05.08.2024 | Vanda Pharmaceuticals: Navigating Challenges and Opportunities in the Biopharmaceutical Landscape | Vanda Pharmaceuticals is at a crossroads. The company recently reported its second-quarter financial results for 2024, revealing a mix of growth and challenges. With revenues of $50.5 million, Vanda saw a 6% increase from the previous quart... |
| 31.07.2024 | Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results | Revenues for Q2 2024 were $50.5 million, an increase of 6% compared to Q1 2024 and an increase of 10% compared to Q2 2023
Financial Guidance reinstated for Full Year 2024
Fanapt® approved for the acute treatment of bipolar I disorder; comme... |
| 12.07.2024 | Collective digital leadership: Why non-technical leaders should share tech ownership | In today's hyper-competitive, rapidly evolving market, the demand for seamless digital interactions has never been higher. The modern workforce expects seamless digital interactions, instant access to information, and intuitive tools that s... |
| 01.07.2024 | illumex: $13 Million Closed To Automate Creation Of A Semantic Layer That Unifies Data Silos | illumex, a Generative Semantic Fabric platform for structured enterprise data, announced that it has raised $13 million in seed funding. The round was led by Cardumen Capital, Amdocs Ventures, and Samsung Ventures, with participation from I... |
| 28.06.2024 | Illumex Revolutionizes Structured Data for Generative AI | Illumex Technologies Inc. secures $13 million in funding to enhance structured data for generative AI, addressing challenges and adding semantic meaning and context.
Big-data readiness startup Illumex Technologies Inc. has closed a $13 mill... |
| 28.06.2024 | "From Us to All: Diversity, Equity, Inclusion" Great Place to Work® recognizes the Best Workplaces™ in Hong Kong for 2024 | HONG KONG, June 28, 2024 /PRNewswire/ -- Great Place to Work® proudly announces the successful conclusion of the Best Workplaces™ in Hong Kong 2024 Awards Ceremony, held at the W Hotel in West Kowloon on June 27, 2024. The ceremony celebrat... |
| 27.06.2024 | illumex Secures $13 Million Funding to Enable Trustworthy, Governed Enterprise GenAI with Structured Data | The platform acts as an intermediate layer that reconciles data silos and automatically adds context and meaning to data, enabling reliable and transparent AI initiatives
illumex, the Generative Semantic Fabric platform for structured enter... |
| 27.06.2024 | The Harris Poll Announces Sponsorship of the 20th Anniversary Pharma PR & Communications Summit | The Stagwell (STGW) agency will share guidance for communicators during the 2024 election cycle
NEW YORK, June 27, 2024 /PRNewswire/ -- The Harris Poll is once again sponsoring the Fierce Pharma PR & Communications Summit, the premier e... |
| 24.06.2024 | Elite Litigators Names Childers Schlueter Smith Best Law Firm For Paragard IUD Victims | ATLANTA , June 24, 2024 /PRNewswire/ -- Elite Litigators has named Childers Schlueter Smith the best law firm in the country for representing victims of defective Paragard IUD medical devices. The recognition is largely attributed to the ex... |
| 15.05.2024 | Fewer U.S., Indiana overdose deaths reported last year, but experts cautious | - |
| 08.05.2024 | Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results | Revenues for Q1 2024 were $47.5 million, an increase of 5% compared to Q4 2023
Cash increase of $5.9 million in Q1 2024 to $394.1 million
Fanapt® approved for the acute treatment of bipolar I disorder; commercial launch expected in Q3 2024
... |
| 04.05.2024 | Илон Маск бьет своих и дружит с китайцами, а японцы скрывают стратегические разработки: дайджест новостей | Массовые увольнения под новую стратегию Tesla, истребление фальшивых фармпатентов, очередные достижения Китая в ИИ. О главном за неделю в мире интеллектуальной собственности — в нашем дайджесте.
Кадровая резня имени Маска: всё ради фокуса н... |
| 24.04.2024 | Pharma exports rise around 10% to $27.9 billion, US biggest importer | - |
| 19.04.2024 | How will Israel's attack on Iran impact the stock market, crude oil, gold? | - |
| 15.04.2024 | Women of Influence: Health Care 2024 – Ileana Hernandez | - |
| 15.04.2024 | Israel outweighs Iran in trade with India since 2019, shows data | - |
| 11.04.2024 | Over 6,000 Indian workers to reach Israel by May to help labour shortage | - |
| 03.04.2024 | Biden touts inhaler price drops with Bernie Sanders: "Finally, finally we beat big Pharma" | Sen. Bernie Sanders and President Biden joined forces Wednesday at the White House, championing the progress they've made on lowering the cost of inhalers and other expenses for Americans with asthma.
Mr. Biden and Sanders also called on Co... |
| 29.03.2024 | Health | Experts say Medicaid rebate change is behind inhaler price cuts | Lauren Clason | (TNS) CQ-Roll Call
A recent tweak to a Medicaid formula could be behind the shake-up to inhaler products, a series of changes that have both benefited and harmed patients with asthma and chronic obstructive pulmonary disease... |
| 13.03.2024 | Contraceptives Market Growth Soars: Aiming for $50.6 Billion by 2030 with 6.5% CAGR | AMR | Contraceptives Market Report
WILMINGTON, DELAWARE, UNITED STATES, March 13, 2024 /EINPresswire.com/ -- Allied Market Research has recently unveiled a research study titled "Contraceptives Market Outlook and Forecast 2020-2030." Th... |
| 13.03.2024 | Pregabalin Market to Reach $2.2Billion Globally, By 2032 at 3% CAGR: Allied Market Research | - |
| 12.03.2024 | Opioid Use Disorder Market to Reach USD 6.15 Billion by 2030, Driven by Growing Focus on Addiction Treatment | Opioid Use Disorder (OUD) Market
Opioid Use Disorder Market Analysis, Industry Trends and Growth Outlook AUSTIN, TEXAS, UNITED STATES, March 12, 2024 /EINPresswire.com/ -- The global opioid use disorder market is experiencing significant gr... |
| 09.03.2024 | CVS Pharmacy to Settle for $10 Million for Alaska Opioid Crisis | March 8, 2024
(Anchorage, AK) – The State of Alaska filed a complaint and consent judgment Thursday against chain pharmacy CVS to close out the settlement process that began two years ago involving the opioid crisis in Alaska.
Once the se... |
| 06.03.2024 | Capecitabine Global Market Report 2024 | - |
| 04.03.2024 | Esomeprazole Market Size Worth $3.22 Billion by 2033; Escalating Incidences of GERD to Propel Growth | - |
| 30.06.2023 | Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin Hydrochloride Injection USP 5 mg/5 mL Due to the Presence of Particulate Matter | COMPANY ANNOUNCEMENT This recall has been completed and FDA has terminated this recall.
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endors... |
| 07.06.2023 | Attorney General Ford Announces $193 Million Settlement with Teva Pharmaceuticals | Carson City, NV – Today, Nevada Attorney General Aaron D. Ford announced that Nevada will receive approximately $193 million from Teva Pharmaceuticals after the company agreed to a settlement regarding its role in the opioid epidemic. With ... |
| 17.11.2022 | Rimidi Showcases New Module for Respiratory Disease Management at HLTH 2022, Designed to Deliver Better Treatment Decisions | Digital therapeutics, like the Digihaler® platform, are making new data available to clinicians in the management of complex diseases and we are thrilled to bring that data into the clinical workflow as part of our platform.”
ATLANTA (PRWEB... |
| 02.09.2022 | Meet the Founder: To tackle stress, Big Pharma veteran Rachel Yarcony launched a foodtech startup | Some years ago, the World Health Organization (WHO) called stress “the health epidemic of the 21st century.” While WHO made this declaration in a pre-Covid-19 world, the pandemic and its subsequent impacts didn’t render stress any less a co... |
| 27.07.2022 | $4.4 Billion Opioid Settlement Gives Teva Stock a Boost | After almost a decade of legal battles, the extraordinary complicated tangle of lawsuits seeking to hold drugmakers and other companies responsible for the opioid crisis seems to be finally coming to an end.
Late Tuesday, generic drugmaker ... |
| 23.05.2022 | Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules, USP 0.5 mg Due to Dissolution Test Failure | COMPANY ANNOUNCEMENT
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product... |
| 10.05.2022 | Teva Publishes 2021 ESG Progress Report, Showcasing Further Integration of ESG Into Business, Robust Targets and Strengthened ESG Governance Structure | Environmental, Social and Governance (ESG) efforts integrated into business strategy with strengthened oversight, robust targets and sustainability-linked bond (SLB)
Progress toward targets to improve access to medicines, including launch o... |
| 22.03.2022 | Teva reaches $100M settlement with Rhode Island for decade of anti-narcotic drugs and $21M cash | Kåre Schultz, the top dog at Teva Pharmaceuticals, said last month on a Q4 call that the pharma giant was confident it could reach a nationwide settlement over its role in the US opioid epidemic within a year’s time.
While ... |
| 09.02.2022 | Teva Pharmaceutical Industries : Reports Fourth Quarter and Full Year 2021 Financial Results - Form 8-K | Teva Reports Fourth Quarter and Full Year 2021 Financial Results
TEL AVIV, Israel--(BUSINESS WIRE)--February 9, 2022--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the year and the quarter ended Decemb... |
| 06.01.2022 | Seattle Children's collaboration to dive into cell therapy manufacturing; After success in court, Teva found guilty in NY | A cell and gene therapy company is extending its collaboration with Seattle Children’s Hospital to establish manufacturing practices for cell therapy, the company announced Tuesday.
BioLife’s new lentiviral vec... |
| 25.11.2021 | Quantum Genomics : Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd. | Press release
Paris, November 25, 2021
Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd.
Quantum Genomics will receive up to $11 M in payments and 25% minimum up to 30% royalties on future sales
Teva will receive a... |
| 27.10.2021 | Teva Reports Third Quarter 2021 Financial Results - Form 8-K | Teva Reports Third Quarter 2021 Financial Results
Revenues of $3.9 billion
GAAP diluted EPS of $0.26
Non-GAAP diluted EPS of $0.59
Cash flow generated from operating activities of $529 million
Free cash flow of $795 million
Full year 2021 b... |
| 19.10.2021 | Is This The Most Exciting Medical Breakthrough Of The Decade | LONDON, Oct. 19, 2021 /PRNewswire/ -- According to Google's Health boss David Feinberg... over one billion people a day search Google for health concerns. But, what if, instead... they could "consult" a phone app with the power of... |
| 19.10.2021 | Is This The Most Exciting Medical Breakthrough Of The Decade | FN Media Group Presents Oilprice.com Market Commentary
LONDON, Oct. 19, 2021 /PRNewswire/ -- According to Google's Health boss David Feinberg... over one billion people a day search Google for health concerns. But, what if, instead... they ... |
| 28.07.2021 | Teva Pharmaceutical Industries : Reports Second Quarter 2021 Financial Results (Form 8-K) | Teva Reports Second Quarter 2021 Financial Results
Revenues of $3.9 billion
GAAP diluted EPS of $0.19
Non-GAAP diluted EPS of $0.59
Cash flow generated from operating activities of $218 million
Free cash flow of $625 million
2021 revenue ou... |
| 23.06.2021 | Teva Pharmaceutical Industries : Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease (COPD... | Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced its U.S. launch of the first generic version of twice daily PERFOROMIST®, formoterol fumarate inhalation solution, 20 mcg/2... |
| 17.05.2021 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Teva Pharmaceutical Industries : Announces the U.S. Launch of the First Generic Version of THIOLA® (tiopronin) tablets | Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced its launch of the first available generic version, in the U.S., of THIOLA® (tiopronin) tablets, indicated, in combination w... |
| 04.05.2021 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Teva Pharmaceutical Industries : Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bacterial Infections, in the Un... | Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of its 250 mg and 500 mg strength generic Erythromycin tablets—a therapeutic equivalent for the reference listed... |
| 23.04.2021 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Teva Pharmaceutical Industries : Announces Launch of its Generic Version of Canasa® (mesalamine) Suppositories To Treat Adults with Active Ulcerative Proctitis ... | Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of its 1000 mg strength generic version of Casana®1 (mesalamine) suppository medicine used to treat ad... |
| 07.12.2020 | After coronavirus vaccine success, is Israel’s MigVax still needed? | Despite encouraging news that at least three vaccines provide some protection against COVID-19, leading Israeli medical entrepreneurs say additional vaccine and treatment options are still needed to end the pandemic.
“There will be other va... |
| 27.08.2020 | Generic drugmaker Teva indicted in alleged price-fixing conspiracy leading consumers to be overcharged by $350M | “Today’s charge reaffirms that no company is too big to be prosecuted for its role in conspiracies that led to substantially higher prices for generic drugs relied on by millions of Americans,” Assistant Attorney General Makan Delrahim, who... |
| 17.03.2020 | Generic ‘identity’ gets lost when companies juggle both generic and brand drugs | We think we know generic drug companies. They challenge patents held by brand firms. They litigate vigorously to overturn those patents. And they often win these challenges.
But what about “generic” companies that play both sides, earning r... |
| 26.11.2019 | Merck adds another OK to Keytruda scoreboard; Ardelyx, Kyowa Kirin broadens partnership beyond tenapanor | → Merck‘s anti-PD-1 blockbuster, Keytruda, is racking up win after win. The newest jewel to the crown for the company is the Chinese approval of the therapy in combination with carboplatin and paclitaxel for the first-l... |